Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Ebola

    - PMLiVE

    David Weinreich appointed as Merck’s Global Head of R&D and CMO, Healthcare

    Weinreich will be based in Billerica, Massachusetts at the company’s Research and Development site

    - PMLiVE

    WHO urges US to ‘reconsider’ withdrawal from global health organisation

    President Donald Trump said the agency mishandled the COVID-19 pandemic and other global health crises

    - PMLiVE

    WHO launches $1.5bn emergency appeal to tackle ongoing health crises

    The appeal is aimed at providing urgent humanitarian assistance to more than 300 million people

    - PMLiVE

    WHO announces priority endemic pathogens for urgent vaccine development

    The study identifies the 17 pathogens that regularly cause diseases in communities

    - PMLiVE

    MSD’s Welireg recommended by NICE to treat rare von Hippel-Lindau disease

    Approximately one in every 70,000 people are affected by the tumour-causing genetic disease

    - PMLiVE

    WHO announces new mRNA vaccine development initiative against human avian influenza

    H5N1 was responsible for 889 cases and 463 deaths across 23 countries from 2003 to 2024

    - PMLiVE

    Merck and Daiichi Sankyo to jointly develop T-cell engager in deal worth over $170m

    The partners will evaluate MK-6070 as part of a combination treatment for small cell lung cancer

    - PMLiVE

    WHO and CEPI call for broader research strategy to prepare for future pandemics

    They have highlighted the importance of expanding research to entire families of pathogens

    - PMLiVE

    Merck and Astellas/Pfizer’s bladder cancer combination receives positive CHMP opinion

    More than 165,000 new cases of bladder cancer are diagnosed in the EU every year

    - PMLiVE

    Merck’s Keytruda combination recommended by NICE for advanced gastric cancer

    More than 6,500 new cases of gastric cancer are diagnosed in the UK every year

    - PMLiVE

    WHO calls for better medicines access to close neurological disorders treatment gap

    In 2021, neurological conditions affected more than three billion people worldwide

    - PMLiVE

    Merck’s investigational RSV monoclonal antibody clesrovimab shown to protect infants

    The respiratory virus accounts for about 30,000 hospitalisations in children under five every year in the UK

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links